Cara Therapeutics (CARA) shares tumbled 22% in recent Friday premarket activity, shaving Thursday's surge.
Novo Nordisk (NVO) stock slumped 20% after it said its experimental obesity therapy CagriSema met the primary endpoint in a phase 3 trial as it showed superior weight loss compared to a placebo, but the results fell short of its expectations.
NIKE (NKE) stock was down 7.2%, a day after it reported lower fiscal Q2 earnings and revenue from a year earlier.
United States Steel (X) shares slipped 6%, after saying Thursday it expects a Q4 adjusted net loss per diluted share between $0.29 and $0.25. Analysts polled by FactSet expect non-GAAP earnings per share of $0.04.
Tesla (TSLA) stock fell almost 5% after the National Highway Traffic Safety Administration said Thursday that the EV maker is recalling 694,304 vehicles in the US over a problem with the tire pressure monitoring system.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。